Suppr超能文献

与E2F结合的视网膜母细胞瘤肿瘤抑制蛋白的晶体结构及其调控的分子基础。

Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation.

作者信息

Xiao Bing, Spencer James, Clements Adrienne, Ali-Khan Nadeem, Mittnacht Sibylle, Broceño Cristina, Burghammer Manfred, Perrakis Anastassis, Marmorstein Ronen, Gamblin Steven J

机构信息

Division of Protein Structure, National Institute for Medical Research, Mill Hill, London NW7 1AA, United Kingdom.

出版信息

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2363-8. doi: 10.1073/pnas.0436813100. Epub 2003 Feb 21.

Abstract

The retinoblastoma tumor suppressor protein (pRb) regulates the cell cycle, facilitates differentiation, and restrains apoptosis. Furthermore, dysfunctional pRb is thought to be involved in the development of most human malignancies. Many of the functions of pRb are mediated by its regulation of the E2F transcription factors. To understand the structural basis for this regulation, we have determined the crystal structure of a fragment of E2F in complex with the pocket domain of the tumor suppressor protein. The pRb pocket, comprising the A and B cyclin-like domains, is the major focus of tumourigenic mutations in the protein. The fragment of E2F used in our structural studies, residues 409-426 of E2F-1, represents the core of the pRb-binding region of the transcription factor. The structure shows that E2F binds at the interface of the A and B domains of the pocket making extensive interactions with conserved residues from both. We show by solution studies that a second site, probably contained within the "marked box" region of E2F, is responsible for additional interactions with the pRb pocket but is insufficient for complex formation on its own. In addition, we show that the interaction of the core binding fragment of E2F with pRb is inhibited by phosphorylation of the tumor suppressor protein by CDK2cyclin DE. Finally, our data reveal that the tight binding of the human papillomavirus E7 oncoprotein to pRb prevents subsequent interactions with the marked box region of E2F but not with its core binding region.

摘要

视网膜母细胞瘤肿瘤抑制蛋白(pRb)调节细胞周期,促进分化,并抑制细胞凋亡。此外,功能失调的pRb被认为与大多数人类恶性肿瘤的发生有关。pRb的许多功能是通过其对E2F转录因子的调节来介导的。为了了解这种调节的结构基础,我们确定了E2F片段与肿瘤抑制蛋白口袋结构域复合物的晶体结构。pRb口袋由A和B细胞周期蛋白样结构域组成,是该蛋白致瘤突变的主要焦点。我们结构研究中使用的E2F片段,即E2F-1的409-426位残基,代表了转录因子pRb结合区域的核心。该结构表明,E2F在口袋结构域的A和B结构域的界面处结合,与两者的保守残基广泛相互作用。我们通过溶液研究表明,第二个位点可能包含在E2F的“标记框”区域内,负责与pRb口袋的额外相互作用,但仅凭其自身不足以形成复合物。此外,我们表明,CDK2-细胞周期蛋白DE对肿瘤抑制蛋白的磷酸化会抑制E2F核心结合片段与pRb的相互作用。最后,我们的数据表明,人乳头瘤病毒E7癌蛋白与pRb的紧密结合会阻止其随后与E2F标记框区域的相互作用,但不会阻止与E2F核心结合区域的相互作用。

相似文献

1
Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation.
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2363-8. doi: 10.1073/pnas.0436813100. Epub 2003 Feb 21.
2
Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Mol Cell Biol. 2001 Jul;21(14):4773-84. doi: 10.1128/MCB.21.14.4773-4784.2001.
3
Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
Biochemistry. 2002 Dec 31;41(52):15625-34. doi: 10.1021/bi0268910.
4
Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
Genes Dev. 1996 Apr 1;10(7):851-61. doi: 10.1101/gad.10.7.851.
5
Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
Biochem Biophys Res Commun. 1999 Sep 16;263(1):35-40. doi: 10.1006/bbrc.1999.1296.
7
Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein.
Oncogene. 2001 Sep 27;20(43):6152-63. doi: 10.1038/sj.onc.1204793.
10
Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.
Mol Cell Biol. 2000 May;20(10):3497-509. doi: 10.1128/MCB.20.10.3497-3509.2000.

引用本文的文献

3
Structural and functional analysis of cancer-associated missense variants in the retinoblastoma protein pocket domain.
J Biol Chem. 2025 Mar;301(3):108284. doi: 10.1016/j.jbc.2025.108284. Epub 2025 Feb 10.
5
Exploring treatment options in cancer: Tumor treatment strategies.
Signal Transduct Target Ther. 2024 Jul 17;9(1):175. doi: 10.1038/s41392-024-01856-7.
6
An intermediate Rb-E2F activity state safeguards proliferation commitment.
Nature. 2024 Jul;631(8020):424-431. doi: 10.1038/s41586-024-07554-2. Epub 2024 Jun 26.
7
Emerging New Therapeutics for Retinoblastoma.
Ocul Oncol Pathol. 2022 Nov;8(3):149-155. doi: 10.1159/000524919. Epub 2022 May 9.
8
The Four Homeostasis Knights: In Balance upon Post-Translational Modifications.
Int J Mol Sci. 2022 Nov 21;23(22):14480. doi: 10.3390/ijms232214480.
10
RB1 loss triggers dependence on ESRRG in retinoblastoma.
Sci Adv. 2022 Aug 19;8(33):eabm8466. doi: 10.1126/sciadv.abm8466.

本文引用的文献

1
Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis.
J Natl Cancer Inst. 2002 Jan 16;94(2):129-42. doi: 10.1093/jnci/94.2.129.
2
The role of p53 and pRB in apoptosis and cancer.
Curr Opin Genet Dev. 2002 Feb;12(1):60-6. doi: 10.1016/s0959-437x(01)00265-9.
4
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
Biochim Biophys Acta. 2001 Mar 21;1471(3):M123-33. doi: 10.1016/s0304-419x(01)00019-1.
5
Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen.
EMBO J. 2001 Jan 15;20(1-2):295-304. doi: 10.1093/emboj/20.1.295.
7
Protein microcrystals and the design of a microdiffractometer: current experience and plans at EMBL and ESRF/ID13.
Acta Crystallogr D Biol Crystallogr. 1999 Oct;55(Pt 10):1765-70. doi: 10.1107/s0907444999009348.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验